Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation

Summary

The purpose of the study is to examine the effect of saxagliptin, an anti-diabetes medication, on hepatic and myocardial fat content and monocyte inflammation in patients with Impaired Glucose Tolerance (IGT).

Timeline

Start

2012-02

Primary completion

2017-08-25

Completion

2017-08-25

Drugs

Indications